Lundbeck
HLUN-B.CO
#2582
Rank
C$7.71 B
Marketcap
$8.10
Share price
-0.98%
Change (1 day)
28.32%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Lundbeck (HLUN-B.CO) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : C$3.37 Billion

According to Lundbeck 's latest financial reports the company's total liabilities are C$3.37 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Lundbeck - Total liabilities on balance sheet (from 2009 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31C$3.01 B-7.38%
2022-12-31C$3.25 B2.55%
2021-12-31C$3.17 B-20.9%
2020-12-31C$4.01 B-3.94%
2019-12-31C$4.18 B128.69%
2018-12-31C$1.82 B19.08%
2017-12-31C$1.53 B-23.27%
2016-12-31C$2.00 B-21.51%
2015-12-31C$2.54 B11.05%
2014-12-31C$2.29 B14.55%
2013-12-31C$2.00 B35.87%
2012-12-31C$1.47 B7.29%
2011-12-31C$1.37 B11.96%
2010-12-31C$1.22 B-27.22%
2009-12-31C$1.68 B47.35%
2008-12-31C$1.14 B14.08%
2007-12-31C$1.00 B-0.09%
2006-12-31C$1.00 B31.75%
2005-12-31C$0.76 B-4.97%
2004-12-31C$0.80 B